InvestorNOR Posted - 23 minutes from now

$GCTK Come on you fat cow. Give us a xmas rally

InvestorNOR Posted - 3 hours ago

@VizTheWin Its two democratics of diabetics. One is the casual diabetics who isnt in life threatening condition and they want smallest as possible monitor. Accuracy not super important. And then you have those who can die if they dont follow their routine to the dot. They need blood measurements and they will opt for the $GCTK device. The extra benefit are 3 years life expectancy before needing surgery again vs 1 year for the $SENS device

VizTheWin Posted - 3 hours ago

$SENS vs $GCTK ; did some research and that GCTK sensor is freaking huge, and you have to route the catheter portion into a vein. I think SENS will win out sooner obviously, but GCTK is a different approach taking reading off blood. How does it do it for so long, considering most blood monitoring is protein based, which breaks down? At 4MC it doesn't look good, but I bought 20k shares anyways, who knows (Needs a pumper)... With SENS, we need some strong sales numbers before this lifts off (I think). Load up now, or sell me your shares cheap :).

lyn30 Posted - 7 hours ago

$GCTK Anytime premarket or after hours just fill the gaps

InvestorNOR Posted - 19 hours ago

$SENS $GCTK Thats why I think Dexcom will buy out GlucoTrack to take on Senseonic. All in the management of Glucotrack are ex Dexcom employees. Insane good value right now to buy shares in GCTK imho

JInvestTrade Posted - 19 hours ago

@InvestorNOR I haven’t change my thought on $GCTK. I have said this company is still years away from FDA approval according to their timeline.

InvestorNOR Posted - 19 hours ago

$GCTK 3 year + CGM. $SENS 1 year life expectancy... JInvestTrade: 2026 is maybe the target year of commercialization of GlucoTrack. But we shall see. There is room in the market for both Senseonic and GlucoTrack. GL

lyn30 Posted - 23 hours ago

$MIST March 27. PDUFA date Analyst pt $13 $GCTK Float 11.28M Huge gap to fill IMO $FAAS 3rd and final round PayMate and DigiAsia which is expected to take up to 60 days. Subsequent to the closing of the Proposed Transaction

InvestorNOR Posted - 1 day ago

$GCTK Its gonna fill the gap over $1 for sure. Any buyout rumor will be over $5 per share. Positive results in Jan or Feb could push this to $2+. Takes absolutely no buy volume at all to push this 30-50% up. Positive news or some pump group deciding to buy will push this easily up towards $1.5-2

JInvestTrade Posted - 1 day ago

$GCTK this could be the next $SENS. The only problem with $GCTK is that $SENS could have a 2 year CGM by the time $GCTK releases their CGM in 2028. https://youtube.com/shorts/hBrLCH4NgmQ?si=7gviD5jG-6vXjRm_

VizTheWin Posted - 1 day ago

$GCTK just bought 20k shares, let's see if this makes me any money...

lyn30 Posted - 1 day ago

$GCTK Float 11.28M Huge gap to fill IMO Anytime may run and fill the gap imo

Putnik Posted - 2 days ago

$GCTK

dumb_investor_8 Posted - 2 days ago

$GCTK I forgot which filing I read it in, but there are like 3 million warrants at 25 cents. That's gotta be why this has hit a floor here. ATTENTION ALL MEDICAL INVESTORS - Want to invest in a start up that's ran by industry insiders, currently running it's first human trial? Oh and the stock has completely bottomed out. Get in, the water is warm

headsortails2066 Posted - 2 days ago

$GCTK All Aboard! Very

VizTheWin Posted - 2 days ago

$GCTK why the 90% dip in a month?

dumb_investor_8 Posted - 2 days ago

$GCTK Got another 5k shares, sitting at 25k shares now.. Wish me luck!!!

Putnik Posted - 2 days ago

$GCTK

JInvestTrade Posted - 2 days ago

@dumb_investor_8 there is currently no other CGM that is FDA approved to last 1 year. $GCTK could be next CGM, but according to their time line that is 3 years away. I do agree that this could be a good trade leading to the data.

InvestorNOR Posted - 2 days ago

$GCTK They will get bought out for $100M+ before end of 2025 is my guess.

InvestorNOR Posted - 2 days ago

$GCTK Well we are about 4-5 weeks from news regarding the preclinical test they are conducting

JInvestTrade Posted - 2 days ago

@JackFlaps @Core366 It might be possible, but $GCTK is years away from any product. Look at $SENS. It has taken them almost 10 years to have a CGM that last 1 year.

Core366 Posted - 2 days ago

$SENS $GCTK $DXCM $ABT The difference is glucotrack will read direct blood, not interstitial fluid and one calibration and 3 years no worries. Plus there will be other uses for their tech. Look at the BOD and management,,,they are OG dexcom scientists and engineers...and John ballantyne who sold his co founded company to danaher for 9.6 billion is a 10% majority shareholder and a director who financed their human trials 3 million debt to equity believes in the company

JInvestTrade Posted - 2 days ago

$SENS 1 year CGM. $GCTK nothing yet. $dxcm. Last 10 days, $ABT last 14 days.

headsortails2066 Posted - 2 days ago

$GCTK New investors ... congrats on getting in before this gets crowded. We wait. Very

InvestorNOR Posted - 3 days ago

$GCTK Come on, give us a bounce in to Xmas

headsortails2066 Posted - 3 days ago

$GCTK CEO of GlucoTrack not only has unbelievable track record with other medical companies BUT is credited with OVER 100 PATENTS that led to DEXCOM $DXCM Continuous Glucose Monitor. Our CEO here was a pioneer of the company that is presently the market leader in the industry at $80 right now! We wait. Very

headsortails2066 Posted - 3 days ago

$GCTK BOOM!!

Cresskill198 Posted - 3 days ago

$GCTK price target: $1.20 (market cap $18 mil) by 12/31/24 $5 (market cap $75 mil) by 12/31/25 $25 (market cap $375 mil) by 12/31/26 $100 (market cap $1.5 bil) by 12/31/27

JInvestTrade Posted - 3 days ago

$GCTK this company still has years to go before the product is available. Look at $SENS. It has a product and the only CGM that last 365 days with weekly calibration. They will take market share from both $DXCM and $ABBV .